SMFG
ABBV icon

Sumitomo Mitsui Financial Group’s AbbVie ABBV Stock Holding History

Sumitomo Mitsui Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,230
Closed -$253K – 228
2025
Q1 		$253K Buy
+1,230
New +$239K ﹤0.01% 111
2018
Q2 		– Sell
-2,130
Closed -$202K – 103
2018
Q1 		$202K Buy
+2,130
New +$234K 0.02% 71

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sumitomo Mitsui Financial Group's ABBV Position: Q2 2025 in Review

Sumitomo Mitsui Financial Group sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,230 shares — an estimated $253K sold.

Sumitomo Mitsui Financial Group first reported a position in ABBV in Q1 2018 and held it in 2 quarters. The position peaked at $253K in Q1 2025. 3,787 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Sumitomo Mitsui Financial Group reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Sumitomo Mitsui Financial Group sold 1,230 AbbVie shares in Q2 2025, an estimated $253K.
  • Sumitomo Mitsui Financial Group first reported a position in AbbVie in Q1 2018 and held it in 2 quarters.
  • Sumitomo Mitsui Financial Group's AbbVie position peaked at $253K in Q1 2025.
  • 3,787 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.